StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report issued on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
NASDAQ:SRNE opened at $0.01 on Monday. The company has a 50-day moving average of $0.01 and a 200-day moving average of $0.02. Sorrento Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.25.
About Sorrento Therapeutics
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- What Are Some of the Best Large-Cap Stocks to Buy?
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- What are earnings reports?
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.